Feedback / Questions
LYL273 - Lyell Immunopharma
https://www.globenewswire.com/news-release/2025/11/10/3184422/0/en/Lyell-Immunopharma-Acquires-Exclusive-Global-Rights-to-a-Next-Generation-CAR-T-Cell-Product-Candidate-in-Clinical-Development-for-Metastatic-Colorectal-Cancer.html
Nov 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next